Detalles de la búsqueda
1.
Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study.
Front Immunol
; 12: 815812, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35095916
2.
Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot Study.
Front Immunol
; 12: 709861, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34475873
Resultados
1 -
2
de 2
1
Próxima >
>>